FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956668712> ?p ?o ?g. }

• W2956668712 endingPage "377" @default.
• W2956668712 startingPage "372" @default.
• W2956668712 abstract "Pemphigus vulgaris (PV) is a blistering, life-threatening autoimmune disease. Ethylenediaminetetraacetic acid (EDTA)-treated desmoglein (Dsg) enzyme-linked immunosorbent assay (ELISA) has recently been suggested to detect nonpathogenic antibodies. Rituximab (RTX) is now considered a first-line treatment for PV.The primary and secondary aims were to evaluate anti-Dsg and EDTA-treated anti-Dsg ELISA and clinical response before and 3 months after RTX in treatment-naïve and previously treated patients, respectively. In addition, we compared the short-term efficacy of RTX between these groups.Seventy-five patients with PV who received RTX (500 mg weekly for 4 weeks or 1000 mg 2 weeks apart) and prednisolone were followed for 3 months. Thirty-seven treatment-naïve newly diagnosed (group A) and 38 relapsed patients (group B) were included. Disease activity was scored with the Pemphigus Disease Area Index (PDAI). Clinical response was also assessed. Serum samples were collected at two points and examined for anti-Dsg1/3 and EDTA-treated anti-Dsg1/3. Conformational anti-Dsg values were calculated by subtracting EDTA-treated from conventional anti-Dsg values.The correlation of conventional and conformational anti-Dsg values was perfect (correlation coefficient > 0.98; p < .001) at every time point for both anti-Dsgs. There was no difference with regard to PDAI and anti-Dsg values between the two groups at baseline. The frequency of responders was significantly higher in group A (100%) than in group B (89%; p = .006). Three patients relapsed, and five patients had persistent disease activity in group B. After 3 months, conventional and conformational anti-Dsg values were significantly higher in group B compared with group A (anti-Dsg3: p = .017 and .021, respectively; anti-Dsg1: p = .014 and .016, respectively). Total and scalp PDAI were significantly lower in group A than in group B (p = .042 and .016, respectively).EDTA-treated anti-Dsg ELISA had no added value. Using RTX as first-line treatment in patients with PV appears to be associated with better clinical response and immunologic profile than delayed treatment in the short term." @default.
• W2956668712 created "2019-07-23" @default.
• W2956668712 creator A5005662518 @default.
• W2956668712 creator A5014368565 @default.
• W2956668712 creator A5037131203 @default.
• W2956668712 creator A5041410495 @default.
• W2956668712 creator A5047775427 @default.
• W2956668712 creator A5080464508 @default.
• W2956668712 creator A5083790612 @default.
• W2956668712 date "2019-12-01" @default.
• W2956668712 modified "2023-10-18" @default.
• W2956668712 title "Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab" @default.
• W2956668712 cites W1976253514 @default.
• W2956668712 cites W1979057766 @default.
• W2956668712 cites W1990861950 @default.
• W2956668712 cites W2016323249 @default.
• W2956668712 cites W2033480007 @default.
• W2956668712 cites W2043488619 @default.
• W2956668712 cites W2044914944 @default.
• W2956668712 cites W2047535890 @default.
• W2956668712 cites W2053968177 @default.
• W2956668712 cites W2066258961 @default.
• W2956668712 cites W2066569606 @default.
• W2956668712 cites W2074833255 @default.
• W2956668712 cites W2076802877 @default.
• W2956668712 cites W2094097966 @default.
• W2956668712 cites W2096463706 @default.
• W2956668712 cites W2119486039 @default.
• W2956668712 cites W2122715855 @default.
• W2956668712 cites W2138617521 @default.
• W2956668712 cites W2167868817 @default.
• W2956668712 cites W2170800914 @default.
• W2956668712 cites W2185764773 @default.
• W2956668712 cites W2285589028 @default.
• W2956668712 cites W2410613420 @default.
• W2956668712 cites W2440035713 @default.
• W2956668712 cites W2566591624 @default.
• W2956668712 cites W2602517913 @default.
• W2956668712 cites W2726907951 @default.
• W2956668712 cites W2753034023 @default.
• W2956668712 cites W2756129260 @default.
• W2956668712 cites W2767836039 @default.
• W2956668712 cites W2767861622 @default.
• W2956668712 cites W2787771368 @default.
• W2956668712 cites W2794565900 @default.
• W2956668712 cites W2804005576 @default.
• W2956668712 cites W2894783582 @default.
• W2956668712 cites W2902329515 @default.
• W2956668712 cites W2921953672 @default.
• W2956668712 cites W3025778652 @default.
• W2956668712 doi "https://doi.org/10.1016/j.ijwd.2019.05.008" @default.
• W2956668712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6938821" @default.
• W2956668712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31909160" @default.
• W2956668712 hasPublicationYear "2019" @default.
• W2956668712 type Work @default.
• W2956668712 sameAs 2956668712 @default.
• W2956668712 citedByCount "9" @default.
• W2956668712 countsByYear W29566687122020 @default.
• W2956668712 countsByYear W29566687122021 @default.
• W2956668712 countsByYear W29566687122022 @default.
• W2956668712 crossrefType "journal-article" @default.
• W2956668712 hasAuthorship W2956668712A5005662518 @default.
• W2956668712 hasAuthorship W2956668712A5014368565 @default.
• W2956668712 hasAuthorship W2956668712A5037131203 @default.
• W2956668712 hasAuthorship W2956668712A5041410495 @default.
• W2956668712 hasAuthorship W2956668712A5047775427 @default.
• W2956668712 hasAuthorship W2956668712A5080464508 @default.
• W2956668712 hasAuthorship W2956668712A5083790612 @default.
• W2956668712 hasBestOaLocation W29566687121 @default.
• W2956668712 hasConcept C126322002 @default.
• W2956668712 hasConcept C159654299 @default.
• W2956668712 hasConcept C163764329 @default.
• W2956668712 hasConcept C203014093 @default.
• W2956668712 hasConcept C2779075594 @default.
• W2956668712 hasConcept C2779134260 @default.
• W2956668712 hasConcept C2780380361 @default.
• W2956668712 hasConcept C2780653079 @default.
• W2956668712 hasConcept C2781313415 @default.
• W2956668712 hasConcept C2781327288 @default.
• W2956668712 hasConcept C2910519024 @default.
• W2956668712 hasConcept C45189115 @default.
• W2956668712 hasConcept C67326383 @default.
• W2956668712 hasConcept C71924100 @default.
• W2956668712 hasConcept C90924648 @default.
• W2956668712 hasConceptScore W2956668712C126322002 @default.
• W2956668712 hasConceptScore W2956668712C159654299 @default.
• W2956668712 hasConceptScore W2956668712C163764329 @default.
• W2956668712 hasConceptScore W2956668712C203014093 @default.
• W2956668712 hasConceptScore W2956668712C2779075594 @default.
• W2956668712 hasConceptScore W2956668712C2779134260 @default.
• W2956668712 hasConceptScore W2956668712C2780380361 @default.
• W2956668712 hasConceptScore W2956668712C2780653079 @default.
• W2956668712 hasConceptScore W2956668712C2781313415 @default.
• W2956668712 hasConceptScore W2956668712C2781327288 @default.
• W2956668712 hasConceptScore W2956668712C2910519024 @default.
• W2956668712 hasConceptScore W2956668712C45189115 @default.
• W2956668712 hasConceptScore W2956668712C67326383 @default.
• W2956668712 hasConceptScore W2956668712C71924100 @default.

• next